Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
Anna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, Roberto Cairoli, Marco MontilloDepartment of Hematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy Abstract: Treatment aim for chronic lymphocytic leukemia has been radically changed over the past years from p...
Main Authors: | Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-09-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | https://www.dovepress.com/clinical-utility-and-patient-considerations-in-the-use-of-ofatumumab-i-peer-reviewed-article-BTT |
Similar Items
-
Role of ofatumumab in treatment of chronic lymphocytic leukemia
by: Veliz M, et al.
Published: (2011-05-01) -
The Emerging Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia
by: Chadi Nabhan, et al.
Published: (2011-01-01) -
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
by: Laurenti L, et al.
Published: (2016-01-01) -
Ofatumumab – a valid treatment option for chronic lymphocytic leukemia patients
by: AlDallal SM
Published: (2017-07-01) -
The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
by: Jorge Castillo, et al.
Published: (2010-02-01)